Chemoinformaics analysis of 4-Ethoxybenzoic acid
| Molecular Weight | 166.176 | nRot | 3 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 7 |
| Exact Molecular Weight | 166.063 | nRing | 1 |
| Solubility: LogS | -2.757 | nHRing | 0 |
| Solubility: LogP | 2.524 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.1039 |
| nHD | 1 | BPOL | 12.6361 |
| QED | 0.744 |
| Synth | 1.273 |
| Natural Product Likeliness | -0.653 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.782 |
| MDCK | 0.0000147 |
| BBB | 0.46 |
| PPB | 0.845066 |
| VDSS | 0.195 |
| FU | 0.116938 |
| CYP1A2-inh | 0.159 |
| CYP1A2-sub | 0.127 |
| CYP2c19-inh | 0.089 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.038 |
| CYP2c9-sub | 0.233 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.108 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.118 |
| CL | 3.126 |
| T12 | 0.875 |
| hERG | 0.131 |
| Ames | 0.009 |
| ROA | 0.074 |
| SkinSen | 0.067 |
| Carcinogencity | 0.114 |
| EI | 0.979 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.880056 |